Detalhe da pesquisa
1.
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Blood
; 140(9): 1009-1019, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544601
2.
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling.
Haematologica
; 108(4): 1105-1114, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770529
3.
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
Br J Haematol
; 190(3): 385-393, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32150297
4.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256379
5.
Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.
Br J Haematol
; 187(3): 347-355, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290569
6.
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739705
7.
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
J Clin Oncol
; : JCO2301386, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359378
8.
A case report of extramedullary plasmocytoma-rare pathology in the larynx.
Clin Case Rep
; 11(9): e7884, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720710
9.
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Lancet Haematol
; 10(12): e966-e975, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922925
10.
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.
J Clin Oncol
; 40(1): 40-51, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388022
11.
Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial.
Cancers (Basel)
; 13(19)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638428
12.
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.
Blood Adv
; 5(19): 3760-3775, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478526
13.
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
J Clin Oncol
; 38(29): 3377-3387, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730183
14.
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Blood Cancer J
; 12(9): 125, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055987